Gomez, Mario
Seybold, Ulrich
Roider, Julia
Härter, Georg
Bogner, Johannes R.
Article History
Received: 21 June 2018
Accepted: 25 September 2018
First Online: 29 September 2018
Change Date: 19 November 2018
Change Type: Correction
Change Details: The original version of this article unfortunately contained mistakes.
Compliance with ethical standards
:
: This study was approved by the “Ethikkommission der Medizinischen Fakultät der Universität München” (Project Nr: 17-602).
: The corresponding author MG is a current employee of Janssen-Cilag GmbH. US reports travel and conference support by Gilead Sciences GmbH, Janssen-Cilag GmbH, and Bristol-Myers Squibb GmbH, lecture honoraria by Gilead Sciences GmbH and MSD Sharp & Dohme GmbH, as well as honoraria for consulting and advisory boards by ViiV Healthcare GmbH. JR states no conflicts of interests. GH reports lecture honoraria by AbbVie Deutschland GmbH & Co. KG, Falk Foundation e.V., Gilead Sciences GmbH, Janssen-Cilag GmbH, MSD Sharp & Dohme GmbH, and ViiV Healthcare, and honoraria for advisory boards by Gilead Sciences GmbH, and Janssen-Cilag GmbH. JRB reports lecture honoraria by AbbVie Deutschland GmbH & Co. KG, Gilead Sciences GmbH, Hexal AG, MSD Sharp & Dohme GmbH, Janssen-Cilag GmbH and ViiV Healthcare and honoraria for advisory boards by AbbVie Deutschland GmbH & Co. KG, Hexal AG, MSD Sharp & Dohme GmbH, Janssen-Cilag GmbH and ViiV Healthcare.